JP2015514681A - 下痢を伴う過敏性腸症候群の処置方法 - Google Patents

下痢を伴う過敏性腸症候群の処置方法 Download PDF

Info

Publication number
JP2015514681A
JP2015514681A JP2014551482A JP2014551482A JP2015514681A JP 2015514681 A JP2015514681 A JP 2015514681A JP 2014551482 A JP2014551482 A JP 2014551482A JP 2014551482 A JP2014551482 A JP 2014551482A JP 2015514681 A JP2015514681 A JP 2015514681A
Authority
JP
Japan
Prior art keywords
hydroxy
alkyl
bowel syndrome
irritable bowel
diarrhea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014551482A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514681A5 (enExample
Inventor
上野　隆司
隆司 上野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of JP2015514681A publication Critical patent/JP2015514681A/ja
Publication of JP2015514681A5 publication Critical patent/JP2015514681A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/558—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing oxygen as the only ring hetero atom, e.g. thromboxanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2014551482A 2012-04-23 2013-04-19 下痢を伴う過敏性腸症候群の処置方法 Pending JP2015514681A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261637082P 2012-04-23 2012-04-23
US61/637,082 2012-04-23
US201261718924P 2012-10-26 2012-10-26
US61/718,924 2012-10-26
PCT/JP2013/062309 WO2013161973A1 (en) 2012-04-23 2013-04-19 Method for treating irritable bowel syndrome with diarrhea

Publications (2)

Publication Number Publication Date
JP2015514681A true JP2015514681A (ja) 2015-05-21
JP2015514681A5 JP2015514681A5 (enExample) 2016-06-02

Family

ID=49380683

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014551482A Pending JP2015514681A (ja) 2012-04-23 2013-04-19 下痢を伴う過敏性腸症候群の処置方法

Country Status (7)

Country Link
US (1) US20130281526A1 (enExample)
EP (1) EP2841065A4 (enExample)
JP (1) JP2015514681A (enExample)
CN (2) CN108685929A (enExample)
CA (1) CA2870252A1 (enExample)
TW (1) TWI594751B (enExample)
WO (1) WO2013161973A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016203317A1 (en) * 2015-06-19 2016-12-22 Sucampo Ag Pharmaceutical compositions comprising fatty acid derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05006981A (es) * 2002-12-27 2005-12-14 Sucampo Ag Derivados de prostaglandinas para el tratamiento de la molestia abdominal.
TWI387454B (zh) * 2004-09-02 2013-03-01 蘇坎波公司 治療胃腸道疾病之方法及組成物
US20070254050A1 (en) * 2006-05-01 2007-11-01 Quart Barry D Method for treatment of diarrhea-predominant irritable bowel syndrome
WO2009045985A1 (en) * 2007-10-01 2009-04-09 The University Of Chicago Treatment of drug-induced nausea with opioid antagonists
CN101318948B (zh) * 2008-04-01 2011-04-27 上海天伟生物制药有限公司 鲁比前列酮晶体、其制备方法及用途
WO2009131200A1 (ja) * 2008-04-25 2009-10-29 協和発酵キリン株式会社 過敏性腸症候群治療剤
CN103919804A (zh) * 2008-05-01 2014-07-16 利发利希奥公司 治疗消化功能紊乱的组合物和方法
JPWO2010016552A1 (ja) * 2008-08-07 2012-01-26 武田薬品工業株式会社 過敏性腸症候群治療薬
EP2778685B1 (en) * 2009-06-25 2017-04-26 Nestec S.A. Methods for diagnosing irritable bowel syndrome
US20110034424A1 (en) * 2009-06-30 2011-02-10 Sucampo Ag Method for the long term nsaid use
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali

Also Published As

Publication number Publication date
CN108685929A (zh) 2018-10-23
CN104379140A (zh) 2015-02-25
TWI594751B (zh) 2017-08-11
US20130281526A1 (en) 2013-10-24
CA2870252A1 (en) 2013-10-31
TW201347757A (zh) 2013-12-01
EP2841065A1 (en) 2015-03-04
WO2013161973A1 (en) 2013-10-31
EP2841065A4 (en) 2015-09-16

Similar Documents

Publication Publication Date Title
US6982283B2 (en) Method for treating drug-induced constipation
JP5686819B2 (ja) 黄斑浮腫を処置するための医薬組成物
KR101164838B1 (ko) 복부 불쾌감 치료용 프로스타글랜딘의 유도체
JP2018150354A (ja) 胃腸障害処置用プロスタグランジン誘導体
JP2010532314A (ja) Ｎｓａｉｄおよびプロスタグランジン化合物の医薬的組み合わせ
JP5427029B2 (ja) 消化管の重炭酸分泌を促進するための方法および組成物
JP2014510022A (ja) 眼精疲労の処置方法
RU2488398C2 (ru) Фармацевтическая комбинация опиоида и простагландинового соединения
JP6193230B2 (ja) 統合失調症の処置方法
JP6641263B2 (ja) 神経障害性疼痛の処置方法
JP2015514681A (ja) 下痢を伴う過敏性腸症候群の処置方法
US20100305203A1 (en) Method for modulating claudin mediated functions
KR20000069446A (ko) 문맥압 상승 억제제
US8569279B2 (en) Method for modulating claudin mediated functions
AU2010296307A1 (en) Pharmaceutical combination for treating tumor
JP2014515004A (ja) イオン輸送体の調節方法
WO2016067620A1 (en) Method and composition for treating nonerosive reflux disease
US20170042908A1 (en) Method for treating geographic atrophy associated with age-related macular degeneration

Legal Events

Date Code Title Description
RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20141215

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20141215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160330

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20160330

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20161206

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170303

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20170501

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20170725